Oxycodone Market Top Companies, Growth rate, Cost Structures and Opportunities to 2027
                     Oxycodone Market To Reach USD 
6.78 Billion By 2026 |Johnson & 
Johnson, Sanofi, Pfizer, Purdue 
Pharma 
www.reportsanddat
a.com
       Market  Summary
The oxycodone market is driven by an increase in 
the number of patients suffering from terminally ill 
diseases.
Market Size – USD 4.68 Billion in 2018, Market 
Growth - CAGR of 4.6%, Market Trends – Expanding 
occurrence of diseases that cause chronic pain, such 
as postsurgical pain, back pain, cancer and 
fibromyalgia is boosting the market.
            M  a Orkuetr  S Aumpmparroyach
The Oxycodone Market is estimated to grow from USD 4.68 Billion in 2018 to USD 6.78 Billion by 2026, at a CAGR of 
4.6%, during the forecast period. The oxycodone market is driven by an increase in the number of patients suffering 
from terminally ill diseases such as cancer and HIV and a high increase in the prescription of post-operative pain 
medication.
Cancer's growing commonness, Parkinson's disease, and rheumatic diseases drive the growth of the market. The 
use of oxycodone to relieve post-operative pain under different medical conditions fuels the growth of the market.
Increasing concern about oxycodone abuse, however, is curbing market growth. However, less addictive oxycodone 
drugs approved by the FDA for adults and children are likely to open new gateways in the forecast period for the 
growth of Oxycodone Market.
Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/1286
       M   a r kOeut  Sru Ampmparyoach
Further key findings from the report suggest
• The Oxycodone Market is estimated to grow from USD 4.68 Billion in 2018 to USD 6.78 Billion by 
2026, at a CAGR of 4.6%, during the forecast period. The oxycodone market is driven by an increase 
in the number of patients suffering from terminally ill diseases such as cancer and HIV and a high 
increase in the prescription of post-operative pain medication.
• The market for short acting oxycodone is expected to hold the largest market share at USD 5.09 
Billion by 2026, at a CAGR of 5.5% during the forecast period. An increase in pharmaceutical 
companies new drug applications and the number of products in the pipeline are driving the market 
for oxycodone. Other formulations are coming up on the market, such as controlling the release of 
drugs to improve pain management.
• Based on routes of administration, the oral segment is expected to hold the largest market share 
and is expected to reach USD 2.98 Billion by 2026, at a CAGR of 5.8% during the forecast period. 
Oxycodone is only approved for mouth use in the United States, which is available as tablets and 
oral solutions. However, oxycodone parenteral formulations (brand name OxyNorm) are also 
available worldwide and are widely used in Europe.
To identify the key trends in the industry, click on the link below @ 
https://www.reportsanddata.com/report-detail/oxycodone-market
       M   a r kOeut  Sru Ampmparyoach
Key participants : Johnson & Johnson (US), Sanofi (France), Pfizer (US), Purdue Pharma (US), Endo International 
(Ireland), Teva Pharmaceuticals (Israel), Hikma Pharmaceuticals (UK), Mallinckrodt (UK), Mylan (US), Sun 
Pharmaceutical (India), Impax Laboratories (US), Indivior (UK) and others. 
For the purpose of this study, Reports and Data have segmented the market on the basis of type, routes of 
administration, application, distribution channel and regional analysis.
Type (Kilo Tons) (Revenue, USD Million; 2016-2026)
Short Acting Oxycodone
Long Acting Oxycodone
Routes of Administration (Kilo Tons) (Revenue, USD Million; 2016-2026)
Oral
Sublingual
Intramuscular
Intravenous
Intranasal
Subcutaneous
        M  a  rOkeut  rSu Ampmparyoach
Distribution (Kilo Tons) (Revenue, USD Million; 2016-2026)
Hospital Pharmacies
Retail Pharmacies
Others
Application (Kilo Tons) (Revenue, USD Million; 2016-2026)
De-Addiction
Pain Management
Order Now @ https://www.reportsanddata.com/checkout-form/1286
About Us
   A  b  oOuutr U Aspproach
Reports and Data is a market research and consulting company that provides syndicated research reports, 
customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, 
target and analyze consumer behavior shifts across demographics, across industries and help client’s make a 
smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across 
a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our 
research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and 
Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]